Antimicrobial Stewardship Program: Reducing Antibiotic's Spectrum of Activity Is not the Solution to Limit the Emergence of Multidrug-Resistant Bacteria.

antimicrobial stewardship de-escalation dysbiosis microbiota

Journal

Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404

Informations de publication

Date de publication:
07 Jan 2022
Historique:
received: 07 11 2021
revised: 20 12 2021
accepted: 30 12 2021
entrez: 21 1 2022
pubmed: 22 1 2022
medline: 22 1 2022
Statut: epublish

Résumé

Overconsumption of antibiotics in hospitals has led to policy implementation, including the control of antibiotic prescriptions. The impact of these policies on the evolution of antimicrobial resistance remains uncertain. In this work, we review the possible limits of such policies and focus on the need for a more efficient approach. Establishing a causal relationship between the introduction of new antibiotics and the emergence of new resistance mechanisms is difficult. Several studies have demonstrated that many resistance mechanisms existed before the discovery of antibiotics. Overconsumption of antibiotics has worsened the phenomenon of resistance. Antibiotics are responsible for intestinal dysbiosis, which is suspected of being the source of bacterial resistance. The complexity of the intestinal microbiota composition, the impact of the pharmacokinetic properties of antibiotics, and the multiplicity of other factors involved in the acquisition and emergence of multidrug-resistant organisms, lead us to think that de-escalation, in the absence of studies proving its effectiveness, is not the solution to limiting the spread of multidrug-resistant organisms. More studies are needed to clarify the ecological risk caused by different antibiotic classes. In the meantime, we need to concentrate our efforts on limiting antibiotic prescriptions to patients who really need it, and work on reducing the duration of these treatments.

Identifiants

pubmed: 35052947
pii: antibiotics11010070
doi: 10.3390/antibiotics11010070
pmc: PMC8772858
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Nature. 2018 Mar 29;555(7698):623-628
pubmed: 29555994
Pathog Glob Health. 2015 Mar;109(2):68-74
pubmed: 25707874
Intensive Care Med. 2015 Jul;41(7):1181-96
pubmed: 26077053
Antimicrob Resist Infect Control. 2015 Jun 23;4:26
pubmed: 26106476
Antimicrob Agents Chemother. 2007 Aug;51(8):3044-5
pubmed: 17562802
J Glob Antimicrob Resist. 2020 Mar;20:290-297
pubmed: 31415828
J Infect Dis. 1989 Aug;160(2):274-80
pubmed: 2788196
Microorganisms. 2021 Jan 06;9(1):
pubmed: 33418967
Int J Antimicrob Agents. 2021 Sep;58(3):106380
pubmed: 34166776
J Antimicrob Chemother. 2020 Feb 1;75(2):351-361
pubmed: 31778166
Science. 2013 Jul 5;341(6141):1237439
pubmed: 23828941
Nat Med. 2019 Sep;25(9):1370-1376
pubmed: 31406349
J Hosp Infect. 2018 Aug;99(4):390-395
pubmed: 29438727
Gut Microbes. 2020 Nov 9;12(1):1795492
pubmed: 32991820
Proc Natl Acad Sci U S A. 1973 Aug;70(8):2276-80
pubmed: 4209515
Microorganisms. 2020 Feb 17;8(2):
pubmed: 32079318
Lancet. 2014 Nov 8;384(9955):1720
pubmed: 25441203
Clin Infect Dis. 2015 Aug 15;61(4):593-600
pubmed: 25904368
Clin Microbiol Infect. 2016 Jul;22(7):646.e1-4
pubmed: 27126608
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4554-61
pubmed: 20847294
Int J Infect Dis. 2021 Mar;104:617-623
pubmed: 33453395
FEMS Microbiol Ecol. 2014 May;88(2):386-97
pubmed: 24580017
Antimicrob Agents Chemother. 2015 Nov 09;60(1):507-14
pubmed: 26552974
Adv Ther. 2020 Jul;37(7):3083-3096
pubmed: 32462606
Elife. 2020 May 07;9:
pubmed: 32379042
Intensive Care Med. 2007 Sep;33(9):1533-40
pubmed: 17549458
Clin Microbiol Rev. 2016 Apr;29(2):321-47
pubmed: 26960938
Crit Care. 2013 Jul 12;17(4):R140
pubmed: 23849321
Ann Intensive Care. 2017 Nov 10;7(1):113
pubmed: 29127502
Trans Am Clin Climatol Assoc. 1956-1957;68:51-5; discussion 55-8
pubmed: 13486607
BMC Infect Dis. 2015 Apr 25;15:197
pubmed: 25927970
Crit Care Med. 2004 Nov;32(11):2183-90
pubmed: 15640629
Clin Chest Med. 2011 Sep;32(3):517-34
pubmed: 21867820
PLoS Biol. 2008 Nov 18;6(11):e280
pubmed: 19018661
Antimicrob Agents Chemother. 2002 Sep;46(9):3045-9
pubmed: 12183268
Antimicrob Agents Chemother. 1987 Nov;31(11):1718-21
pubmed: 3435120
Science. 2015 Dec 4;350(6265):1214-5
pubmed: 26785481
Clin Microbiol Rev. 2013 Oct;26(4):744-58
pubmed: 24092853
Xenobiotica. 2004 Apr;34(4):379-89
pubmed: 15268982
Intensive Care Med. 2016 Dec;42(12):2098-2100
pubmed: 27430221
Curr Opin Microbiol. 2021 Dec;64:82-90
pubmed: 34688039
Nature. 2011 Aug 31;477(7365):457-61
pubmed: 21881561
Clin Infect Dis. 2016 Oct 1;63(7):937-943
pubmed: 27358350
Antimicrob Agents Chemother. 2011 Dec;55(12):5609-15
pubmed: 21947393
N Engl J Med. 1997 Aug 14;337(7):441-6
pubmed: 9250845
Antimicrob Agents Chemother. 2007 Jan;51(1):372-5
pubmed: 17043115
Nat Commun. 2016 Dec 08;7:13803
pubmed: 27929110
Clin Infect Dis. 2004 Mar 1;38(5):670-7
pubmed: 14986251
J Antimicrob Chemother. 2014 Mar;69(3):786-9
pubmed: 24159154
PLoS One. 2015 Sep 30;10(9):e0138135
pubmed: 26422376
Clin Microbiol Infect. 2018 Jan;24(1):3-5
pubmed: 28970162
Antimicrob Agents Chemother. 2021 Jan 20;65(2):
pubmed: 33168609
Antimicrob Agents Chemother. 2019 May 24;63(6):
pubmed: 30936104
PLoS One. 2020 Aug 28;15(8):e0237260
pubmed: 32857755
Antibiotics (Basel). 2020 Apr 17;9(4):
pubmed: 32316518
J Chemother. 2001 Nov;13 Spec No 1(1):218-23
pubmed: 11936369
World J Gastroenterol. 2005 Feb 28;11(8):1131-40
pubmed: 15754393
J Hosp Infect. 2021 Jul;113:1-9
pubmed: 33932556
Nat Genet. 2014 Apr;46(4):336-44
pubmed: 24562188
Pathol Biol (Paris). 1999 Oct;47(8):836-44
pubmed: 10573704
Biol Blood Marrow Transplant. 2019 Oct;25(10):1933-1943
pubmed: 31195137
Front Microbiol. 2018 Aug 15;9:1908
pubmed: 30158920
Curr Opin Pharmacol. 2011 Oct;11(5):477-85
pubmed: 21840259
Clin Infect Dis. 2007 Sep 15;45 Suppl 3:S177-83
pubmed: 17712744
Science. 2021 Jul 9;373(6551):181-186
pubmed: 34244407
Nutrients. 2021 Aug 15;13(8):
pubmed: 34444955
Intensive Care Med. 2017 Mar;43(3):304-377
pubmed: 28101605
Clin Microbiol Infect. 2015 Jul;21(7):649.e1-10
pubmed: 25882363
Nature. 2011 May 12;473(7346):174-80
pubmed: 21508958
Gut Microbes. 2019;10(5):631-641
pubmed: 30714464
Infect Immun. 2020 Mar 23;88(4):
pubmed: 31964746
Intensive Care Med. 2014 Jan;40(1):32-40
pubmed: 24026297
Int J Antimicrob Agents. 2018 Dec;52(6):762-770
pubmed: 30176355
Microb Ecol Health Dis. 2017 Jan 01;28(1):1345574
pubmed: 28959177
Immunol Rev. 2017 Sep;279(1):90-105
pubmed: 28856737
J Chemother. 1997 Jun;9(3):203-7
pubmed: 9210003
PLoS Pathog. 2012;8(10):e1002995
pubmed: 23133377
Infect Immun. 2020 Mar 23;88(4):
pubmed: 31907198
World J Gastroenterol. 2021 May 21;27(19):2376-2393
pubmed: 34040329
J Antimicrob Chemother. 2017 Jan;72(1):128-136
pubmed: 27707993
Clin Infect Dis. 2016 Apr 15;62(8):1009-1017
pubmed: 26703860
Expert Rev Mol Diagn. 2021 Sep;21(9):911-924
pubmed: 34225544

Auteurs

Rindala Saliba (R)

Infection Control Unit, French-Muslim Hospital, Avicenna, 93000 Bobigny, France.
Clinical Microbiology Department, Hotel-Dieu de France Hospital, Beirut 166830, Lebanon.

Assaf Mizrahi (A)

Service de Microbiologie Clinique, Groupe Hospitalier Paris Saint-Joseph, 75014 Paris, France.

Péan de Ponfilly Gauthier (PP)

Service de Microbiologie Clinique, Groupe Hospitalier Paris Saint-Joseph, 75014 Paris, France.

Le Monnier Alban (LM)

Service de Microbiologie Clinique, Groupe Hospitalier Paris Saint-Joseph, 75014 Paris, France.

Jean-Ralph Zahar (JR)

Infection Control Unit, French-Muslim Hospital, Avicenna, 93000 Bobigny, France.

Benoît Pilmis (B)

Institut Micalis, Unité Mixte de Recherche 1319, Université Paris-Saclay, INRAe, AgroParisTech, 92290 Châtenay Malabery, France.
Equipe Mobile de Microbiologie Clinique, Groupe Hospitalier Paris Saint-Joseph, 75014 Paris, France.

Classifications MeSH